Yutaka Hirayama
Overview
Explore the profile of Yutaka Hirayama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sumitomo R, Menju T, Shimazu Y, Toyazaki T, Chiba N, Miyamoto H, et al.
Cancer Sci
. 2023 Oct;
114(12):4521-4534.
PMID: 37806311
Epithelial-mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed...
2.
Yamada H, Funasaka K, Nakagawa M, Hirayama Y, Horiguchi N, Nagasaka M, et al.
Intern Med
. 2023 Apr;
62(23):3473-3477.
PMID: 37081675
Inflammatory myofibroblastic tumor (IMT) is a rare tumor composed of myofibroblasts with inflammatory blood cell infiltration. It commonly occurs in the lungs and rarely in the esophagus. We herein report...
3.
Kawanaka Y, Yasuda Y, Tanizaki J, Iwashima D, Nonagase Y, Uemasu K, et al.
Respir Investig
. 2022 Jun;
60(5):667-673.
PMID: 35725721
Background: Some lung cancer patients have preexisting interstitial lung disease (ILD), which is considered a risk factor for lung cancer treatment. This study investigated the safety and efficacy of durvalumab...
4.
Yasuda Y, Mutsuo S, Hamada M, Murai K, Hirayama Y, Uemasu K, et al.
Infect Dis Rep
. 2022 Apr;
14(2):250-257.
PMID: 35447882
Background: Aluminium reduces severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) survival in experimental settings. It is unknown whether adding an aluminium gauze to a mask reduces the SARS-CoV-2 RNA load...
5.
Yasuda Y, Hirayama Y, Uemasu K, Arasawa S, Iwashima D, Takahashi K
Respir Med Res
. 2022 Mar;
81:100903.
PMID: 35316675
Background: Remdesivir with dexamethasone and remdesivir with baricitinib are effective in coronavirus disease 2019 (COVID-19) patients. However, there has been few evidence regarding the efficacy of the combination of baricitinib,...
6.
Tajika M, Tanaka T, Ishihara M, Hirayama Y, Onishi S, Mizuno N, et al.
Nagoya J Med Sci
. 2021 Dec;
83(4):787-799.
PMID: 34916722
Currently, the same-day polyethylene glycol-electrolyte lavage solution (PEG-ELS) regimen is particularly recommended for afternoon colonoscopy as an alternative to the split-dose regimen in western countries. However, in Japan, the split-dose...
7.
Kitaoka A, Tanimura K, Yasuda Y, Nishioka K, Hirayama Y, Uemasu K, et al.
IDCases
. 2021 Nov;
26:e01337.
PMID: 34840954
We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the first cycle of carboplatin/etoposide treatment, febrile neutropenia...
8.
Uemasu K, Yasuda Y, Hirayama Y, Arasawa S, Iwashima D, Takahashi K
J Infect Chemother
. 2021 Nov;
28(2):321-325.
PMID: 34810106
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which leads to critical pneumonia, although the clinical courses vary. In some cases, COVID-19 pneumonia causes...
9.
Dayde D, Gunther J, Hirayama Y, Weksberg D, Boutin A, Parhy G, et al.
Cancers (Basel)
. 2021 Jul;
13(14).
PMID: 34298853
The current standard of care for patients with locally advanced rectal cancer (LARC) is neoadjuvant chemoradiation (nCRT) followed by total mesorectal excision surgery. However, the response to nCRT varies among...
10.
Nakaya K, Iinuma Y, Hirayama Y, Sugai Y, Taki S
Case Rep Pediatr
. 2021 Jan;
2020:8832856.
PMID: 33489399
Inflammatory bowel disease is rare in infants, and the early diagnosis is very important. We herein report an infant who received an early diagnosis of infantile Crohn's disease (CD). A...